Yakira Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Yakira Capital Management’s Portfolio SGTX Stock Details SGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,746	Closed	-$895K	–	426
2023 Q2	$895K	Buy	+39,746	New	+$288K	0.24%	97

Other funds holding SGTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Yakira Capital Management's SGTX Position: Q3 2023 in Review

Yakira Capital Management sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 39,746 shares — an estimated $895K sold.

Yakira Capital Management first reported a position in SGTX in Q2 2023 and held it in 1 quarter. The position peaked at $895K in Q2 2023. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

Yakira Capital Management reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Yakira Capital Management sold 39,746 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $895K.
Yakira Capital Management first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Yakira Capital Management's Sigilon Therapeutics, Inc. Common Stock position peaked at $895K in Q2 2023.
1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Yakira Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.